George Washington University to enroll 500 people in COVID-19 vaccine trial

In an attempt to contribute towards curbing the Coronavirus pandemic, George Washington University is now participating in the third phase of the COVID 19 vaccine trial. 

The final stage began on Monday and is participated from thousands of Americans nationwide. On a local level, 500 people would be enrolled along with several volunteers.

The trials are for a vaccine developed by the National Institute of Allergy and Infectious Diseases and by a company called Moderna Inc. The chief of the mentioned institute is the celebrated expert Dr. Anthony Fauci.

However, there are certain conditions required to be fulfilled by the participants in order to be a part of the human trials.

They should have reached a minimum of eighteen years of age. Participants who would come from across the nation are to have a co-existence of health conditions such as Diabetes and Obesity. Also, at least 25% of these people should be around Sixty five years old.

This is precisely to test the vaccine’s effectiveness in people who have a greater risk of the infection. Each person would be given a dose of two injections, with a month’s span in between and then would be checked for two years after the second shot.

“COVID-19 is one of the greatest public health challenges of our time, and it is of utmost importance to find a safe and effective vaccine,” said Dr. David Diemert, the principal investigator of the clinical trial at GW, in a statement.

Read on